CAVATICA Launch: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance Cancer Moonshot Goals
Today, the Children’s Brain Tumor Tissue Consortium, the Pacific Pediatric Neuro-Oncology Consortium, and Seven Bridges announce the release of CAVATICA, a data analysis platform designed to facilitate the rapid integration of data from multiple diseases affecting children, including cancer and other rare diseases like congenital disorders, epilepsy, and autism. Birth defects and neurological disorders have been linked to an increased incidence of cancer, however, uncovering these connections has been slowed because data generated to understand pediatric cancer cannot be easily compared to data generated for research into other rare diseases. CAVATICA will immediately make available more than 24 datasets for collaborative discovery spanning pediatric cancer to congenital heart defects, and these datasets will be interoperable with the Genomic Data Commons and other NIH data repositories to drive progress in our understanding and treatment of childhood cancer.
By making large volumes of genomic and other types of data from multiple diseases available, within a system researchers can use to share and analyze it, CAVATICA is answering the Cancer Moonshot’s call to de-silo data and make it more useful to a wide range of researchers, so that faster progress can be made to fight pediatric cancer and other childhood diseases.
To view the complete Cancer Moonshot Report, visit https://www.whitehouse.gov/the-press-office/2016/10/17/fact-sheet-vice-president-biden-delivers-cancer-moonshot-report
Children’s Brain Tumor Tissue Consortium (CBTTC) Webinar Fall 2016
Children’s Brain Tumor Tissue Consortium (CBTTC) Webinar Fall 2016.
The webinar featured a panel discussion including Dr. Rishi Lulla, who was recently appointed as Executive Chair of the CBTTC, Dr. Adam Resnick, Scientific Chair of the CBTTC, and Dr. Jay Storm, Division Chief of Neurosurgery at The Children’s Hospital of Philadelphia. Additionally, learn more about Dr. Lulla and the current research landscape of the CBTTC.
To view the webinar, click here